id: NEW:biomarker_feedback_intervention_to_binge_drinking
name: Biomarker-Based Feedback Intervention for Alcohol Use â†’ Binge Drinking
from_node:
  node_id: NEW:biomarker_feedback_intervention
  node_name: Biomarker-Based Feedback Intervention for Alcohol Use
to_node:
  node_id: binge_drinking
  node_name: Binge Drinking
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Healthcare systems integrate biomarker testing (liver injury markers, fibrosis tests) into
  routine alcohol care'
- 'Step 2: Clinicians provide personalized advice to patients based on objective biomarker results showing
  liver damage'
- 'Step 3: Tangible biological evidence of harm increases patient perception of risk and severity'
- 'Step 4: Enhanced risk perception motivates behavior change and reduction in alcohol consumption'
- 'Step 5: Sustained reduction in weekly alcohol intake reduces binge drinking episodes'
evidence:
  quality_rating: A
  n_studies: 16
  primary_citation: 'Mohsan Subhani et al. 2021. "Does Advice Based on Biomarkers of Liver Injury or Non-Invasive
    Tests of Liver Fibrosis Impact High-Risk Drinking Behaviour: A Systematic Review With Meta-analysis.."
    https://doi.org/10.1093/alcalc/agaa143'
  supporting_citations:
  - Studies included 14 randomized controlled trials and 2 observational studies (specific citations require
    full-text access)
  - Additional citations require full-text access for individual RCT details
  - Additional citations require full-text access for observational study details
  doi: 10.1093/alcalc/agaa143
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Adding advice based on biomarkers of liver injury or non-invasive tests of liver fibrosis
  to routine care significantly reduces weekly alcohol consumption by 74.4 g/week compared to standard
  care without biomarker feedback.
quantitative_effects:
  effect_size:
    value: -74.4
    type: standardized_mean_difference
    ci_lower: -126.1
    ci_upper: -22.6
  p_value: 0.005
  sample_size: 3763
moderators:
- name: Type of biomarker used
  direction: strengthens
  strength: moderate
  description: Both liver injury biomarkers and non-invasive liver fibrosis tests showed effectiveness,
    though specific comparative efficacy not detailed
structural_competency:
  equity_implications: This mechanism addresses healthcare system-level intervention rather than individual
    blame. The structural component involves integrating biomarker testing into routine alcohol care protocols,
    making early identification and personalized intervention accessible as part of standard healthcare
    delivery. The effectiveness depends on healthcare system capacity to implement such screening and
    counseling, highlighting structural barriers in healthcare access and quality.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.015810'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
